Mac Overmyer
Higher surgeon volume linked to lower RALP costs
A study from the UCLA Ronald Reagan Medical Center appears to once again prove that time is money. The study’s findings indicate that up to $15 million could be saved annually by referring patients who are candidates for robot-assisted radical prostatectomy to surgeons and surgical centers with optimal operating times.
Robotic nephrectomy on the rise, but why?
The advantages that robotic technologies bring to prostate procedures, partial nephrectomies, and other surgeries that can involve complex reconstruction are not readily apparent in simple extirpative surgeries such as radical nephrectomy. This raises two questions: Are robots being used in radical nephrectomies and if so, why?
Protocol may eliminate need for opioids after robot-assisted laparoscopic prostatectomy
More than 85% of patients undergoing robot-assisted laparoscopic prostatectomy may not require opioid analgesia either immediately post-op, in hospital, or upon release, according to a recent study.
Surgery type has no effect on high-risk prostate cancer outcomes
Type of surgical approach—open or robot assisted—appears to have no effect on specific clinical outcomes in patients undergoing radical prostatectomy for high-risk prostate cancer, nor does the procedure influence the pathway subsequent therapy might follow, according to a recent study.
Device may overcome problems of magnetic guidance
A recently developed instrument may improve the adjustment capabilities of a magnetic coupling system being investigated for use in laparoscopic procedures.
Basic laparoscopic suturing skills teachable in 3 hours, according to study
Learning the skills required to execute basic laparoscopic sutures need not be a time-consuming, tedious exercise. Basic moves and skills can be acquired in as little as 3 hours, say researchers from the Ohio State University Medical Center, Columbus.
Robotic, open radical prostatectomy outcomes comparable in high-risk prostate cancer patients
Robot-assisted laparoscopic prostatectomy in patients with intermediate- or high-risk cancers achieves outcomes similar to those seen with the open procedure, say researchers from Vanderbilt University, Nashville, TN.
Neurotoxin may have action in prostate cancer
Researchers have shown, via a phase I trial, that the relationship between nerves and prostate cancer in perineural invasion is susceptible to therapeutic intervention with neurotoxic agents such as onabotulinumtoxinA (Botox).
Concerns for secondary malignancy post-radiation therapy unfounded
The incidence of secondary malignancies following prostate cancer therapy is similarly uncommon whether the treatment is surgery, brachytherapy, or external beam therapy.
Vasectomy reversal outcomes not dependent on time
Two recent studies appear to deal a serious blow to the commonly held belief that the success of a vasectomy reversal and subsequent pregnancy weakens to futility as the interval between the vasectomy and its reversal lengthens.